Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
H.B. Fuller Company reported preliminary results for fiscal year 2024, projecting net revenue of approximately USD 3.57 billion, slightly below the expected USD 3.58 billion. The company also revised its adjusted earnings per share (EPS) outlook to USD 3.84, down from the previously estimated USD 4.16. Furthermore, H.B. Fuller cut its EBITDA guidance to USD 594 million, down from a prior range of USD 610 million to USD 620 million, citing a negative inflection in performance observed late in the fourth quarter due to market weakness and rising costs. Following the announcement, H.B. Fuller shares fell by 3.7% in pre-market trading.
Lifecore Biomedical, $LFCR, Q2 FY25 Results: 🟢 +1.05% Post-Market ($6.73) 📊 EPS: $(0.25) 🟢 💰 Revenue: $32.56M 🟢 📈 Net Loss: $(6.57)M (from $14.22M net income YoY) 🔍 Signed multiple new development agreements & doubled capacity with a new high-speed isolator filler.
Resources Connection, $RGP Q2 FY25 Results: 🟢 +6.08% Post-Market ($9.25) 📊 Adj EPS: $0.18 🟢 💰 Revenue: $145.62M 🟢 📈 Net Income: $(68.72M) 🔍 Revenue grew 6.3% sequentially; Adjusted EBITDA margin rose to 6.6%.
Resources Connection Reports Financial Results for Second Quarter Fiscal 2025 https://t.co/hC7oCtzNQK https://t.co/qa2DoWBrTC